Erschienen in:
04.01.2017 | Breast Oncology
Has the Time Come to Stop Surgical Staging of the Axilla for All Women Age 70 Years or Older with Hormone Receptor-Positive Breast Cancer?
verfasst von:
Judy C. Boughey, MD, Bruce G. Haffty, MD, Elizabeth B. Habermann, PhD, Tanya L. Hoskin, MS, Matthew P. Goetz, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 3/2017
Einloggen, um Zugang zu erhalten
Excerpt
Classically, for patients with invasive breast cancer, surgical management has included axillary staging. Historically, this was performed by axillary lymph node dissection (ALND). Currently, for clinically node-negative disease, sentinel lymph node (SLN) surgery is routinely used to assess the status of the axilla and to determine whether the patient is pathologically node-positive or node-negative. …